469 related articles for article (PubMed ID: 27577965)
1. Embolic protection in patients undergoing transaortic transcatheter aortic valve replacement: initial experience with the TriGuard HDH embolic deflection device.
Campelo-Parada F; Regueiro A; Dumont E; DeLarochellière R; Paradis JM; Mohammadi S; Doyle D; Rodés-Cabau J
J Card Surg; 2016 Oct; 31(10):617-622. PubMed ID: 27577965
[TBL] [Abstract][Full Text] [Related]
2. TriGuard
Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
[TBL] [Abstract][Full Text] [Related]
4. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.
Baumbach A; Mullen M; Brickman AM; Aggarwal SK; Pietras CG; Forrest JK; Hildick-Smith D; Meller SM; Gambone L; den Heijer P; Margolis P; Voros S; Lansky AJ
EuroIntervention; 2015 May; 11(1):75-84. PubMed ID: 25868876
[TBL] [Abstract][Full Text] [Related]
5. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
[TBL] [Abstract][Full Text] [Related]
6. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcome of Transcatheter Aortic Valve Replacement With TriGUARD 3™ Cerebral Embolic Protection Device.
Daal SM; Jimenez-Rodriguez GMJ; Voskuil M; Kraaijeveld AO; Dessing TC; Ramjankhan FZ; Mokhles MM; Stella PR
Cardiovasc Revasc Med; 2023 May; 50():8-12. PubMed ID: 36681530
[TBL] [Abstract][Full Text] [Related]
8. Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT II.
Nazif TM; Moses J; Sharma R; Dhoble A; Rovin J; Brown D; Horwitz P; Makkar R; Stoler R; Forrest J; Messé S; Dickerman S; Brennan J; Zivadinov R; Dwyer MG; Lansky AJ;
JACC Cardiovasc Interv; 2021 Mar; 14(5):515-527. PubMed ID: 33663779
[TBL] [Abstract][Full Text] [Related]
9. Embrella embolic deflection device for cerebral protection during transcatheter aortic valve replacement.
Samim M; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Kluin J; Ramjankhan F; Doevendans PA; Stella PR
J Thorac Cardiovasc Surg; 2015 Mar; 149(3):799-805.e1-2. PubMed ID: 25455466
[TBL] [Abstract][Full Text] [Related]
10. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions.
Onsea K; Agostoni P; Samim M; Voskuil M; Kluin J; Budde R; Hendrikse J; Ramjankhan F; van Klarenbosch J; Doesburg P; Sieswerda G; Stella P
EuroIntervention; 2012 May; 8(1):51-6. PubMed ID: 22580248
[TBL] [Abstract][Full Text] [Related]
11. Cerebral embolic protection systems for transcatheter aortic valve replacement.
Gasior T; Mangner N; Bijoch J; Wojakowski W
J Interv Cardiol; 2018 Dec; 31(6):891-898. PubMed ID: 30467892
[TBL] [Abstract][Full Text] [Related]
12. Protection from Cerebral Embolic Events During Transcatheter Aortic Valve Replacement.
Rossow CF; McCabe JM
Curr Cardiol Rep; 2016 Feb; 18(2):16. PubMed ID: 26768742
[TBL] [Abstract][Full Text] [Related]
13. Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
Van Gils L; Kroon H; Daemen J; Ren C; Maugenest AM; Schipper M; De Jaegere PP; Van Mieghem NM
Catheter Cardiovasc Interv; 2018 Mar; 91(4):790-797. PubMed ID: 28895285
[TBL] [Abstract][Full Text] [Related]
14. A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
Lansky AJ; Makkar R; Nazif T; Messé S; Forrest J; Sharma R; Schofer J; Linke A; Brown D; Dhoble A; Horwitz P; Zang M; DeMarco F; Rajagopal V; Dwyer MG; Zivadinov R; Stella P; Rovin J; Parise H; Kodali S; Baumbach A; Moses J
Eur Heart J; 2021 Jul; 42(27):2670-2679. PubMed ID: 34000004
[TBL] [Abstract][Full Text] [Related]
15. Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Giustino G; Mehran R; Veltkamp R; Faggioni M; Baber U; Dangas GD
JACC Cardiovasc Interv; 2016 Oct; 9(20):2124-2133. PubMed ID: 27765306
[TBL] [Abstract][Full Text] [Related]
16. Impact of a Two-Filter Cerebral Embolic Protection Device on the Complexity and Risk of Transcatheter Aortic Valve Replacement.
Voss S; Deutsch MA; Schechtl J; Erlebach M; Sideris K; Lange R; Bleiziffer S
Thorac Cardiovasc Surg; 2020 Oct; 68(7):616-622. PubMed ID: 31091551
[TBL] [Abstract][Full Text] [Related]
17. Silent ischemic brain lesions after transcatheter aortic valve replacement: lesion distribution and predictors.
Samim M; Hendrikse J; van der Worp HB; Agostoni P; Nijhoff F; Doevendans PA; Stella PR
Clin Res Cardiol; 2015 May; 104(5):430-8. PubMed ID: 25596724
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Difference in Post-procedural Stroke Rates Between Patients with Aortic Stenosis Who Undergo Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement.
Burke H; Boron A; Lee JH; Kahlon KR
Cureus; 2018 Apr; 10(4):e2494. PubMed ID: 29922535
[TBL] [Abstract][Full Text] [Related]
19. Cerebral protection devices during transcatheter aortic valve implantation.
Vlastra W; Vendrik J; Koch KT; Baan J; Piek JJ; Delewi R
Trends Cardiovasc Med; 2018 Aug; 28(6):412-418. PubMed ID: 29428159
[TBL] [Abstract][Full Text] [Related]
20. Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis.
Seeger J; Kapadia SR; Kodali S; Linke A; Wöhrle J; Haussig S; Makkar R; Mehran R; Rottbauer W; Leon M
Eur Heart J; 2019 May; 40(17):1334-1340. PubMed ID: 30590554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
